Plasma biomarkers of astrocytic and neuronal dysfunction in early- and late-onset Alzheimer's disease

Fanny M. Elahi, Kaitlin B. Casaletto, Renaud La Joie, Samantha M. Walters, Danielle Harvey, Amy Wolf, Lauren Edwards, Wilfredo Rivera-Contreras, Anna Karydas, Yann Cobigo, Howard J. Rosen, Charles DeCarli, Bruce L. Miller, Gil D. Rabinovici, Joel H. Kramer

Research output: Contribution to journalArticle

Abstract

Introduction: We investigated plasma proteomic markers of astrocytopathy, brain degeneration, plasticity, and inflammation in sporadic early-onset versus late-onset Alzheimer's disease (EOAD and LOAD). Methods: Plasma was analyzed using ultra-sensitive immuno-based assays from 33 EOAD, 30 LOAD, and 36 functionally normal older adults. Results: Principle component analyses identified 3 factors: trophic (BDNF, VEGF, TGFβ), degenerative (GFAP, NfL), and inflammatory (TNFα, IL-6, IP-10, IL-10). Trophic factor was elevated in both AD groups and associated with cognition and gray matter volumes. Degenerative factor was elevated in EOAD, with higher levels associated with worse functioning in this group. Biomarkers of inflammation were not significantly different between groups and were only associated with age. Disucssion: Plasma proteomic biomarkers provide novel means of investigating molecular processes in vivo and their contributions to clinical outcomes. We present initial investigations of several of these fluid biomarkers, capturing aspects of astrocytopathy, neuronal injury, cellular plasticity, and inflammation in EOAD versus LOAD.

Original languageEnglish (US)
JournalAlzheimer's and Dementia
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Alzheimer Disease
Biomarkers
Inflammation
Proteomics
Brain-Derived Neurotrophic Factor
Cognition
Vascular Endothelial Growth Factor A
Interleukin-6
Wounds and Injuries
Brain
Gray Matter
Cell Plasticity

Keywords

  • Astrocytopathy
  • Brain homeostasis
  • Cerebral small vessel disease
  • Early-onset Alzheimer's disease
  • Exosomes
  • Growth hormones
  • Immune activation
  • Inflammation
  • Late-onset Alzheimer's disease
  • Neurodegeneration
  • White matter disease

ASJC Scopus subject areas

  • Epidemiology
  • Health Policy
  • Developmental Neuroscience
  • Clinical Neurology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health
  • Cellular and Molecular Neuroscience

Cite this

Plasma biomarkers of astrocytic and neuronal dysfunction in early- and late-onset Alzheimer's disease. / Elahi, Fanny M.; Casaletto, Kaitlin B.; La Joie, Renaud; Walters, Samantha M.; Harvey, Danielle; Wolf, Amy; Edwards, Lauren; Rivera-Contreras, Wilfredo; Karydas, Anna; Cobigo, Yann; Rosen, Howard J.; DeCarli, Charles; Miller, Bruce L.; Rabinovici, Gil D.; Kramer, Joel H.

In: Alzheimer's and Dementia, 01.01.2019.

Research output: Contribution to journalArticle

Elahi, FM, Casaletto, KB, La Joie, R, Walters, SM, Harvey, D, Wolf, A, Edwards, L, Rivera-Contreras, W, Karydas, A, Cobigo, Y, Rosen, HJ, DeCarli, C, Miller, BL, Rabinovici, GD & Kramer, JH 2019, 'Plasma biomarkers of astrocytic and neuronal dysfunction in early- and late-onset Alzheimer's disease', Alzheimer's and Dementia. https://doi.org/10.1016/j.jalz.2019.09.004
Elahi, Fanny M. ; Casaletto, Kaitlin B. ; La Joie, Renaud ; Walters, Samantha M. ; Harvey, Danielle ; Wolf, Amy ; Edwards, Lauren ; Rivera-Contreras, Wilfredo ; Karydas, Anna ; Cobigo, Yann ; Rosen, Howard J. ; DeCarli, Charles ; Miller, Bruce L. ; Rabinovici, Gil D. ; Kramer, Joel H. / Plasma biomarkers of astrocytic and neuronal dysfunction in early- and late-onset Alzheimer's disease. In: Alzheimer's and Dementia. 2019.
@article{32278a037a4d4c5697466d59a475a29e,
title = "Plasma biomarkers of astrocytic and neuronal dysfunction in early- and late-onset Alzheimer's disease",
abstract = "Introduction: We investigated plasma proteomic markers of astrocytopathy, brain degeneration, plasticity, and inflammation in sporadic early-onset versus late-onset Alzheimer's disease (EOAD and LOAD). Methods: Plasma was analyzed using ultra-sensitive immuno-based assays from 33 EOAD, 30 LOAD, and 36 functionally normal older adults. Results: Principle component analyses identified 3 factors: trophic (BDNF, VEGF, TGFβ), degenerative (GFAP, NfL), and inflammatory (TNFα, IL-6, IP-10, IL-10). Trophic factor was elevated in both AD groups and associated with cognition and gray matter volumes. Degenerative factor was elevated in EOAD, with higher levels associated with worse functioning in this group. Biomarkers of inflammation were not significantly different between groups and were only associated with age. Disucssion: Plasma proteomic biomarkers provide novel means of investigating molecular processes in vivo and their contributions to clinical outcomes. We present initial investigations of several of these fluid biomarkers, capturing aspects of astrocytopathy, neuronal injury, cellular plasticity, and inflammation in EOAD versus LOAD.",
keywords = "Astrocytopathy, Brain homeostasis, Cerebral small vessel disease, Early-onset Alzheimer's disease, Exosomes, Growth hormones, Immune activation, Inflammation, Late-onset Alzheimer's disease, Neurodegeneration, White matter disease",
author = "Elahi, {Fanny M.} and Casaletto, {Kaitlin B.} and {La Joie}, Renaud and Walters, {Samantha M.} and Danielle Harvey and Amy Wolf and Lauren Edwards and Wilfredo Rivera-Contreras and Anna Karydas and Yann Cobigo and Rosen, {Howard J.} and Charles DeCarli and Miller, {Bruce L.} and Rabinovici, {Gil D.} and Kramer, {Joel H.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.jalz.2019.09.004",
language = "English (US)",
journal = "Alzheimer's and Dementia",
issn = "1552-5260",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Plasma biomarkers of astrocytic and neuronal dysfunction in early- and late-onset Alzheimer's disease

AU - Elahi, Fanny M.

AU - Casaletto, Kaitlin B.

AU - La Joie, Renaud

AU - Walters, Samantha M.

AU - Harvey, Danielle

AU - Wolf, Amy

AU - Edwards, Lauren

AU - Rivera-Contreras, Wilfredo

AU - Karydas, Anna

AU - Cobigo, Yann

AU - Rosen, Howard J.

AU - DeCarli, Charles

AU - Miller, Bruce L.

AU - Rabinovici, Gil D.

AU - Kramer, Joel H.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Introduction: We investigated plasma proteomic markers of astrocytopathy, brain degeneration, plasticity, and inflammation in sporadic early-onset versus late-onset Alzheimer's disease (EOAD and LOAD). Methods: Plasma was analyzed using ultra-sensitive immuno-based assays from 33 EOAD, 30 LOAD, and 36 functionally normal older adults. Results: Principle component analyses identified 3 factors: trophic (BDNF, VEGF, TGFβ), degenerative (GFAP, NfL), and inflammatory (TNFα, IL-6, IP-10, IL-10). Trophic factor was elevated in both AD groups and associated with cognition and gray matter volumes. Degenerative factor was elevated in EOAD, with higher levels associated with worse functioning in this group. Biomarkers of inflammation were not significantly different between groups and were only associated with age. Disucssion: Plasma proteomic biomarkers provide novel means of investigating molecular processes in vivo and their contributions to clinical outcomes. We present initial investigations of several of these fluid biomarkers, capturing aspects of astrocytopathy, neuronal injury, cellular plasticity, and inflammation in EOAD versus LOAD.

AB - Introduction: We investigated plasma proteomic markers of astrocytopathy, brain degeneration, plasticity, and inflammation in sporadic early-onset versus late-onset Alzheimer's disease (EOAD and LOAD). Methods: Plasma was analyzed using ultra-sensitive immuno-based assays from 33 EOAD, 30 LOAD, and 36 functionally normal older adults. Results: Principle component analyses identified 3 factors: trophic (BDNF, VEGF, TGFβ), degenerative (GFAP, NfL), and inflammatory (TNFα, IL-6, IP-10, IL-10). Trophic factor was elevated in both AD groups and associated with cognition and gray matter volumes. Degenerative factor was elevated in EOAD, with higher levels associated with worse functioning in this group. Biomarkers of inflammation were not significantly different between groups and were only associated with age. Disucssion: Plasma proteomic biomarkers provide novel means of investigating molecular processes in vivo and their contributions to clinical outcomes. We present initial investigations of several of these fluid biomarkers, capturing aspects of astrocytopathy, neuronal injury, cellular plasticity, and inflammation in EOAD versus LOAD.

KW - Astrocytopathy

KW - Brain homeostasis

KW - Cerebral small vessel disease

KW - Early-onset Alzheimer's disease

KW - Exosomes

KW - Growth hormones

KW - Immune activation

KW - Inflammation

KW - Late-onset Alzheimer's disease

KW - Neurodegeneration

KW - White matter disease

UR - http://www.scopus.com/inward/record.url?scp=85076981263&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076981263&partnerID=8YFLogxK

U2 - 10.1016/j.jalz.2019.09.004

DO - 10.1016/j.jalz.2019.09.004

M3 - Article

AN - SCOPUS:85076981263

JO - Alzheimer's and Dementia

JF - Alzheimer's and Dementia

SN - 1552-5260

ER -